Prognostic and predictive factors in early-stage breast cancer.
about
Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancerFADD phosphorylation is critical for cell cycle regulation in breast cancer cellsHow do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experimentCancer research: from prognostic genes to therapeutic targetsAGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.Analysis of trastuzumab and chemotherapy in advanced breast cancer after the failure of at least one earlier combination: an observational study.Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapyPrognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy.Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer.Histamine therapeutic efficacy in metastatic melanoma: Role of histamine H4 receptor agonists and opportunity for combination with radiation.Mutations in p53, p53 protein overexpression and breast cancer survivalPrediction of years of life after diagnosis of breast cancer using omics and omic-by-treatment interactions.The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative OncoMerging transcriptomics and metabolomics--advances in breast cancer profiling.Patients with uterine leiomyoma exhibit a high incidence but low mortality rate for breast cancer.Potential Indexing of the Invasiveness of Breast Cancer Cells by Mitochondrial Redox RatiosA pilot study comparing the effect of flaxseed, aromatase inhibitor, and the combination on breast tumor biomarkersMolecular genetics complexity impeding research progress in breast and ovarian cancers.The prediction models for postoperative overall survival and disease-free survival in patients with breast cancerSoluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: results from North Central Cancer Treatment Group adjuvant trial N9831Individual participant data meta-analysis of prognostic factor studies: state of the art?The relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast cancerMembranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancerDiagnosis of second breast cancer events after initial diagnosis of early stage breast cancerImmunoglobulin kappa C predicts overall survival in node-negative breast cancer.Does the axillary lymph node ratio have any added prognostic value over pN staging for South East Asian breast cancer patients?Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteinsMorphologic complexity of epithelial architecture for predicting invasive breast cancer survival.G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasisImpact of preoperative anemia on relapse and survival in breast cancer patients.Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer.Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide?Predictive value of pathological and immunohistochemical parameters for axillary lymph node metastasis in breast carcinoma.Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer.A novel intervention using interactive technology and personal narratives to reduce cancer disparities: African American breast cancer survivor stories.The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.Breast cancer therapy by laser-induced Coulomb explosion of gold nanoparticles.Angiogenesis in Breast Cancer and its Correlation with Estrogen, Progesterone Receptors and other Prognostic Factors.Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?Prediction of breast cancer survival using clinical and genetic markers by tumor subtypes.
P2860
Q24632628-82262302-6D9D-4F0F-B933-5553B1E3DC48Q24652327-8DE181F7-649D-4DFC-8472-B0C9F3FC345EQ24658523-EA09252C-2DE0-4275-93DA-D146F8AFECAAQ28396195-93DFFEC8-9B60-4FD6-BADF-7A7FDE608FEFQ30318240-A81C568B-2960-45CD-BC09-4F8A05E96F01Q33236634-7F503E2C-7392-4A68-9E44-AC309F7FC408Q33568902-FA54E74C-8AE1-4076-80D9-7706B3F50C40Q33609985-E4ADBA1A-8BD9-4E1A-B2EB-9358094AC4F1Q33686729-B1243C7D-DD01-4784-8ED8-000D578B2145Q33688711-E9379C0F-D25D-4891-90D1-4A0B684D126FQ33703486-627C79C9-2588-4731-84AD-69EA6AA6F0F3Q33707489-BB225146-96DE-4351-9E87-C9B2D02C53C5Q33739381-E475B667-A81B-44FA-B12B-6DEA4ACC5595Q33748176-7E819DA4-2EEE-4A69-A780-60904F99335DQ33779337-B9BE5E2E-0ABE-48F8-B25C-D9AFC676CFC7Q33812253-7E94F2FA-ADE0-4361-8392-372EB7A49086Q33830320-009EC96A-0323-4710-9A03-3F1E02FA0467Q33858073-33E04677-021E-4B89-8121-FBCD182DA6B6Q33891155-2FABE69C-8454-43AB-84A7-553A657788DBQ34020878-CEC446D2-F7A5-424F-8F92-16B4578D0B83Q34244162-08FB2A6E-34C3-45E0-A808-3112E84BE456Q34245787-EC923CE6-24EB-488B-8200-375F5D37EDE1Q34284302-0B11F68A-1E9F-4353-9139-E5D311214285Q34292779-5288FB14-1EBF-45AA-A2B2-75248D4FDEACQ34427347-A57DD7C9-B8E5-4A47-9B32-B792966D6822Q34430121-9F1B4D09-1FDE-42D3-801B-6BA92F3BF7F5Q34460058-173C8510-828C-4725-AA1B-DC09624218C8Q34506605-B2095ABE-784B-4A2E-9B15-220F24139E11Q34518541-D29DFD16-8AE7-4422-A2EB-A040ECC3D704Q34565736-2118068D-AB6C-4392-BBCB-8409574628DFQ34582515-5D0EBB77-2D2B-45F6-8022-137C63647E7CQ34600828-DD746321-1B00-4388-A08E-EFC7829547B7Q34748822-29AC67CC-DDCF-432C-888E-198EB7655B63Q34983601-5CD643EB-10DD-4871-913D-18BE13EFCDC8Q34986195-08DFFD41-01E2-4BA4-8483-6509B6FB22B3Q35052176-43703A60-B21D-49B1-B727-CEDBB9129D76Q35079796-2C0762A4-868E-4544-889B-BBEBD050B4A5Q35139611-7E222B11-0A04-49D4-A41F-123B21219B74Q35157568-BD72CA50-4835-4A6D-8379-611768CC6F86Q35389904-3B1FC193-655C-4168-9965-C256B1DD13BE
P2860
Prognostic and predictive factors in early-stage breast cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Prognostic and predictive factors in early-stage breast cancer.
@ast
Prognostic and predictive factors in early-stage breast cancer.
@en
type
label
Prognostic and predictive factors in early-stage breast cancer.
@ast
Prognostic and predictive factors in early-stage breast cancer.
@en
prefLabel
Prognostic and predictive factors in early-stage breast cancer.
@ast
Prognostic and predictive factors in early-stage breast cancer.
@en
P1433
P1476
Prognostic and predictive factors in early-stage breast cancer.
@en
P2093
Lori J Goldstein
Mary Cianfrocca
P304
P356
10.1634/THEONCOLOGIST.9-6-606
P577
2004-01-01T00:00:00Z